AI
GNOM icon

Atria Investments’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Atria Investments’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,630
Closed -$156K – 2073
2025
Q2 		$156K Buy
4,630
+518
+13% +$16.4K ﹤0.01% 1943
2025
Q1 		$131K Buy
4,112
+659
+19% +$25K ﹤0.01% 1864
2024
Q4 		$134K Buy
3,453
+751
+28% +$31.6K ﹤0.01% 1816
2024
Q3 		$122K Buy
+2,702
New +$121K ﹤0.01% 1862

Other funds holding GNOM

FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IA
Insight Advisors Newtown, Pennsylvania $567M AUM 25.52% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Atria Investments's GNOM Position: Q3 2025 in Review

Atria Investments sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 4,630 shares — an estimated $156K sold.

Atria Investments first reported a position in GNOM in Q3 2024 and held it in 4 quarters. The position peaked at $156K in Q2 2025. 43 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

  • Atria Investments reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Atria Investments sold 4,630 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $156K.
  • Atria Investments first reported a position in Global X Genomics & Biotechnology ETF in Q3 2024 and held it in 4 quarters.
  • Atria Investments's Global X Genomics & Biotechnology ETF position peaked at $156K in Q2 2025.
  • 43 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Atria Investments's 13F filing for Q3 2025, filed 6 Nov 2025.